A matching-adjusted indirect comparison of results from REDUCE and RESPECT—two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke

References

• Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236. doi: 10.1161/STR.0000000000000024.
   PubMed Web of Science ®Google Scholar
• World Stroke Organization. Global stroke fact sheet 2022. 2023. https://www.world-stroke.org/assets/downloads/WSO_Global_Stroke_Fact_Sheet.pdf.
   Google Scholar
• Amarenco P, Bogousslavsky J, Caplan LR, et al. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27(5):493–501. doi: 10.1159/000210432.
   PubMed Web of Science ®Google Scholar
• Perera KS, de Sa Boasquevisque D, Rao-Melacini P, et al. Evaluating rates of recurrent ischemic stroke among young adults with embolic stroke of undetermined source: the young ESUS longitudinal cohort study. JAMA Neurol. 2022;79(5):450–458. doi: 10.1001/jamaneurol.2022.0048.
   PubMed Web of Science ®Google Scholar
• Sun YP, Homma S. Patent foramen ovale and stroke. Circ J. 2016;80(8):1665–1673. doi: 10.1253/circj.CJ-16-0534.
   PubMed Web of Science ®Google Scholar
• Teshome MK, Najib K, Nwagbara CC, et al. Patent foramen ovale: a comprehensive review. Curr Probl Cardiol. 2020;45(2):100392. doi: 10.1016/j.cpcardiol.2018.08.004.
   PubMed Web of Science ®Google Scholar
• Garg L, Haleem A, Varade S, et al. Patent foramen ovale closure in the setting of cryptogenic stroke: a meta-analysis of five randomized trials. J Stroke Cerebrovasc Dis. 2018;27(9):2484–2493. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.005.
   PubMed Web of Science ®Google Scholar
• Lattanzi S, Brigo F, Cagnetti C, et al. Patent foramen ovale and cryptogenic stroke or transient ischemic attack: to close or not to close? A systematic review and meta-analysis. Cerebrovasc Dis. 2018;45(5-6):193–203. doi: 10.1159/000488401.
   PubMed Web of Science ®Google Scholar
• Reinthaler M, Ozga AK, Sinning D, et al. Revival of transcatheter PFO closure: a meta-analysis of randomized controlled trials - impact of shunt size and age. Am Heart J. 2018;201:95–102. doi: 10.1016/j.ahj.2018.03.025.
   PubMed Web of Science ®Google Scholar
• Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033–1042. doi: 10.1056/NEJMoa1707404.
   PubMed Web of Science ®Google Scholar
• Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–1100. doi: 10.1056/NEJMoa1301440.
   PubMed Web of Science ®Google Scholar
• Sposato LA, Albin CSW, Elkind MSV, et al. Long-Term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;55(1):236–247. doi: 10.1056/NEJMoa1610057.
   Google Scholar
• Signorovitch JE, Sikirica V, Erder MH, et al. Matching-Adjusted indirect comparisons: a new tool for timely comparative effectiveness research. Value Health. 2012;15(6):940–947. doi: 10.1016/j.jval.2012.05.004.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Instructions for use for: Gore Helex septal occlude. 2023. https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050006c.pdf.
   Google Scholar
• US Food and Drug Administration. Instructions for use for: GORE® CARDIOFORM SEPTAL OCCLUDER. 2023. https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050006s060d.pdf.
   Google Scholar
• GORE. FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke [Internet]. 2018. https://www.gore.com/news-events/press-release/fda-approves-gore-cardioform-septal-occluder-for-pfo-closure.
   Google Scholar
• US Food and Drug Administration. AMPLATZER® PFO Occluder. Instructions for use. 2023. https://www.fda.gov/media/97980/download.
   Google Scholar
• Guyot P, Ades AE, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12(1):9. doi: 10.1186/1471-2288-12-9.
   PubMed Web of Science ®Google Scholar
• Kumar P, Rusheen J, Tobis JM. A comparison of methods to determine patent foramen ovale size. Catheter Cardiovasc Interv. 2020;96(6):E621–E629. doi: 10.1002/ccd.28665.
   PubMed Web of Science ®Google Scholar
• Phillippo DM, Ades AE, Dias S, et al. Methods for population-adjusted indirect comparisons in health technology appraisal. Med Decis Making. 2018;38(2):200–211. doi: 10.1177/0272989X17725740.
   PubMed Web of Science ®Google Scholar
• Darmoch F, Al-Khadra Y, Soud M, et al. Transcatheter closure of patent foramen ovale versus medical therapy after cryptogenic stroke: a meta-analysis of randomized controlled trials. Cerebrovasc Dis. 2018;45(3-4):162–169. doi: 10.1159/000487959.
   PubMed Web of Science ®Google Scholar
• Abdelaziz HK, Saad M, Abuomara HZ, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: a meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2018;92(1):176–186. doi: 10.1002/ccd.27636.
   PubMed Web of Science ®Google Scholar
• Oliva L, Huszti E, Barker M, et al. New-onset atrial fibrillation following percutaneous closure of patent foramen ovale: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2021;60(2):165–174. doi: 10.1007/s10840-020-00925-5.
   PubMed Web of Science ®Google Scholar
• Vukadinović D, Scheller B, Ukena C, et al. Device-related risk of atrial fibrillation after closure of patent foramen ovale: a systematic review and meta-analysis. Clin Res Cardiol. 2022;111(5):583–587. doi: 10.1007/s00392-021-01964-2.
   PubMed Web of Science ®Google Scholar
• Varotto L, Bregolin G, Paccanaro M, et al. Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse? Neurol Sci. 2021;42(1):101–109. doi: 10.1007/s10072-020-04922-4.
   PubMed Web of Science ®Google Scholar
• Skibsted CV, Korsholm K, Pedersen L, et al. Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study. Eur Heart J. 2023;44(36):3469–3477. doi: 10.1093/eurheartj/ehad305.
   PubMed Web of Science ®Google Scholar
• Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019; Oct 740(38):3182–3195. doi: 10.1093/eurheartj/ehy649.
   PubMed Web of Science ®Google Scholar